Business
Verastem Oncology to Present at Jefferies Healthcare Conference
Verastem Oncology to Present at Jefferies Healthcare Conference
About this update from Verastem, Inc.
BOSTON --(BUSINESS WIRE)-- Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that its management team is scheduled to participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 3, 2026 , at 8:10 am ET in New York . A live webcast of the fireside chat can be accessed under “Events & Presentations” on the Company’s website at www.verastem.com . A replay of the webcasts will be archived on the website for approximately 90 days following the presentation. About Verastem Oncology Verastem Oncology (Nasdaq: VSTM) is a biopharmaceutical company committed to developing and commercializing new medicines to improve the lives of patients diagnosed with RAS/MAPK pathway-driven cancers. Verastem markets AVMAPKI® FAKZYNJA® CO-PACK in the U.S. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition , FAK inhibition , and KRAS G12D inhibition . For more information, please visit www.verastem.com and follow us on LinkedIn . View source version on businesswire.com : https://www.businesswire.com/news/home/20260527590882/en/ For Investor and Media Inquiries: Julissa Viana Senior Vice President, Corporate Communications, Investor Relations & Patient Advocacy [email protected] or [email protected] Source: Verastem Oncology